~~UNITED STATES SECURITIES AND EXCHANGE COMMISSION~~`

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 orOR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of ~~earliest event~~earlies event reported): July 2916, ~~2024~~2025

~~Groove~~GROOVE ~~Botanicals~~BOTANICALS ~~Inc~~INC.

(Exact name of registrant as specified in its charter)

Commission File Number: 000-23476

Nevada	000-23476	84-1168832
(State or other jurisdiction of	(Commission File Number)	(I.R.S. Employer
incorporation or organization)		Identification No.)

Nevada		84-1168832
310 Fourth Avenue South, Suite 7000, Minneapolis, MN		554415
(State of incorporation)		(IRS Employer Identification No.)
Address of principal office executive offices		Zip Code

310 Fourth Avenue South, Suite 700, Minneapolis, MN		55415
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: 612-315-5068

Registrant’s telephone number, including area code: (612) 315-5068

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12 (b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered None N/A N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). ~~Emerging growth company ☑~~

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~ITEM~~INFORMATION ~~5.02~~TO ~~Departure~~BE ofINCLUDED ~~Directors~~IN orTHE ~~Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.~~REPORT

~~Resignation~~Item ~~of Mr~~4.02 ~~Douglas Barton~~Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Report

On July 2916, ~~2024~~2025, ~~Groove~~we ~~Botanicals Inc.~~filed ~~(the~~our ~~“Company”)~~annual ~~received~~report for the ~~resignation~~fiscal year ofended ~~Mr.~~March ~~Douglas~~31, ~~Barton~~2025 ason aForm ~~director~~10-K of (the ~~Company.~~“Original MrReport”). ~~Barton~~We ~~did~~filed ~~not~~the ~~resign due~~Original toReport ~~any~~without ~~dispute~~the orwritten ~~disagreement~~consent ~~with~~of our auditors and therefore the ~~Company~~Original orReport ~~its~~should ~~practices~~not be relied upon.

~~Extension~~On August 15, 2025, we filed an amendment to our annual report on Form 10-K/A for the fiscal year ended March 31, 2025, upon receipt of ~~compensation~~the ~~contract~~written consent of our auditors to publish their report contained therein.

OnThe ~~July 30, 2024, the~~ Company’s ~~and Mr.~~board ~~Kent~~of ~~Rodriguez~~directors, ~~CEO~~acting ~~and~~as ~~director~~audit committee, provided ~~agreed~~a tocopy ~~extend the term~~ of anthis ~~Employment~~Current ~~Contract~~Report ~~originally entered into~~ on ~~April~~Form 1,8-K ~~2020~~and ~~expiring March~~discussed ~~31,~~the ~~2024,~~disclosed ~~for~~matters awith ~~further~~its ~~two~~independent ~~year~~registered ~~term~~public toaccounting firm, ~~March~~M.S. ~~31,~~Madhava ~~2026~~Rao, ~~retroactive~~Chartered ~~to April 1~~Accountant, ~~2024.~~prior ~~The agreement designates monthly payments~~ to ~~Kent~~its ~~Rodriguez~~filing inwith the ~~amount~~Securities ofand ~~$4,000~~Exchange ~~or $48,000 per year~~Commission.

~~Item 9.01 Financial Statements and Exhibits.~~SIGNATURES

~~(d)~~ Pursuant ~~Exhibits~~to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit Number		Description
10.1		Letter agreement between the Company and Kent Rodriguez, CEO
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

GROOVE BOTANICALS INC.

Date: August 19, 2025

By: /s/ Kent Rodriguez

Chief Executive Officer

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Groove Botanicals Inc.
	(Registrant)
Date: July 31, 2024	/s/ Kent Rodriguez (Signature)
	Name:	Kent Rodriguez
	Title:	Chief Executive Officer

Filing Compare · GROOVE BOTANICALS INC.